ACE2 expression in saliva of patients with COVID-19 and its association with Candida albicans and Aggregatibacter actinomycetemcomitans [version 2; peer review: 2 approved]

• Published in: F1000 research 2022, Vol.11, p.557
• Main Authors: Bachtiar, Endang W, Bachtiar, Boy M, Kusumaningrum, Ardiana, Sunarto, Hari, Soeroso, Yuniarti, Sulijaya, Benso, Apriyanti, Efa, Theodorea, Citra Fragrantia, Pratomo, Irandi Putra, ., Yudhistira, Efendi, Defi, Razak, Fathilah Abdul
• Format: Article
• Language: English
• Subjects: ACE2; Actin; Aggregatibacter actinomycetemcomitans; Angiotensin; Angiotensin-converting enzyme 2; Bacteria; Biofilms; Candida albicans; Coronaviruses; COVID-19; Diabetes; Diabetes mellitus; Dysbacteriosis; eng; Fusobacterium nucleatum; Gene expression; Genes; Gram-negative bacteria; Laboratories; Microbiota; Microorganisms; Patients; Peptidyl-dipeptidase A; Saliva; Severe acute respiratory syndrome coronavirus 2; Tongue; Veillonella parvula
• ISSN: 2046-1402; 2046-1402
• DOI: 10.12688/f1000research.111965.2

Background: A relationship between oral microbiota and susceptibility to SARS-CoV-2 infection has been extensively studied. However, the relationship between oral commensal flora and expression of angiotensin-converting enzyme 2 ( ACE2) remains to be established. In this observational study, we collected saliva from patients with COVID-19 and evaluated the relationship between ACE2 expression and Candida albicans as well as with selected gram-negative bacteria ( Aggregatibacter actin o mycetemcomitans, Fusobacterium nucleatum, and Veillonella parvula). We investigated how this may be directly or indirectly involved in oral dysbiosis in patients with COVID-19. Methods: We included 23 hospitalized patients admitted to Universitas Indonesia Hospital with PCR-confirmed COVID-19, with six healthy participants serving as controls. Saliva and tongue surface swabs were collected from patients with diabetes (DG) and without diabetes (NDG) and subject controls. Using quantitative PCR (qPCR) we assessed the mRNA expression of ACE2, the abundance of C. albicans, and the transcription levels of its biofilm-associated genes, agglutinin-like protein 3 ( ALS3), hyphal wall protein 1 ( HWP1), and yeast-form wall protein 1 ( YWP1). We also counted the relative proportion of the three selected gram-negative oral bacteria in saliva. All analyses were performed to determine the relationship between ACE2 expression and C. albicans and gram-negative bacteria. Results: ACE2 mRNA expression was significantly higher in tongue swab samples than in saliva. However, no significant difference was observed between the patient groups. Conversely, DG patients had a significantly higher abundance of C. albicans in saliva compared to NDG patients and control group patients. The correlation and sensitivity/specificity relationship between ACE2 expression and C. albicans or the selected oral bacteria were also observed. Conclusions: The data show that ACE2 expression can be detected in saliva of patients with COVID-19 and its association with C. albicans and gram-negative oral bacteria might contribute toward developing an oral dysbiosis based predictor for prognosis of COVID-19 severity.